| Hans-Günter Meyer-Thompson | Naloxon
USA. FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
USA. FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
Nalmefene Hydrochloride Product in Nasal Spray Form Provides Additional Tool for Harm Reduction Groups and First Responders. (FDA – U.S. Food & Drug Administration, USA, 22.05.2023)
https://www.fda.gov/news-events/press-announcements/fda-approves-prescription-nasal-spray-reverse-opioid-overdose